Combination GLP-1 receptor agonist and SGLT2 inhibitor therapy versus GLP-1 receptor agonist monotherapy on arrhythmia outcomes in non-diabetic obese patients: A real-world time-dependent analysis.
- DOI
- 10.1016/j.ijcrp.2026.200681
- Published
- 2026 Sep
- Container
- International journal of cardiology. Cardiovascular risk and prevention
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ijcrp.2026.200681,
title = {Combination GLP-1 receptor agonist and SGLT2 inhibitor therapy versus GLP-1 receptor agonist monotherapy on arrhythmia outcomes in non-diabetic obese patients: A real-world time-dependent analysis.},
author = {Blankson GA and Acheampong IA and Carboo AK and Kumi DD and Amoah J and Nawal A and Nii-Ashie Djanie S and Prempeh I and Seidu A and Buckner RKE},
year = {2026},
journal = {International journal of cardiology. Cardiovascular risk and prevention},
doi = {10.1016/j.ijcrp.2026.200681},
url = {https://doi.org/10.1016/j.ijcrp.2026.200681}
}RIS
TY - JOUR TI - Combination GLP-1 receptor agonist and SGLT2 inhibitor therapy versus GLP-1 receptor agonist monotherapy on arrhythmia outcomes in non-diabetic obese patients: A real-world time-dependent analysis. AU - Blankson GA AU - Acheampong IA AU - Carboo AK AU - Kumi DD AU - Amoah J AU - Nawal A AU - Nii-Ashie Djanie S AU - Prempeh I AU - Seidu A AU - Buckner RKE PY - 2026 JO - International journal of cardiology. Cardiovascular risk and prevention DO - 10.1016/j.ijcrp.2026.200681 UR - https://doi.org/10.1016/j.ijcrp.2026.200681 ER -
APA
GA, B., IA, A., AK, C., DD, K., J, A., A, N., S, N. D., I, P., A, S., & RKE, B. (2026). Combination GLP-1 receptor agonist and SGLT2 inhibitor therapy versus GLP-1 receptor agonist monotherapy on arrhythmia outcomes in non-diabetic obese patients: A real-world time-dependent analysis.. International journal of cardiology. Cardiovascular risk and prevention. https://doi.org/10.1016/j.ijcrp.2026.200681
Source records
- pubmed · retrieved 2026-09-27T14:16:36.662Z